Systematic Review of the Diagnosis and Management of Necrotising Otitis Externa: Highlighting the Need for High-quality Research
Overview
Authors
Affiliations
Objectives: To present a systematic review and critical analysis of clinical studies for necrotising otitis externa (NOE), with the aim of informing best practice for diagnosis and management.
Design: Medline, Embase, Cochrane Library and Web of Science were searched from database inception until 30 April 2021 for all clinical articles on NOE. The review was registered on PROSPERO (ID: CRD42020128957) and conducted in accordance with PRISMA guidelines.
Results: Seventy articles, including 2274 patients were included in the final synthesis. Seventy-three percent were retrospective case series; the remainder were of low methodological quality. Case definitions varied widely. Median patient age was 69.2 years; 68% were male, 84% had diabetes and 10% had no reported immunosuppressive risk factor. Otalgia was almost universal (96%), with granulation (69%) and oedema (76%) the commonest signs reported. Pseudomonas aeruginosa was isolated in 62%, but a range of bacterial and fungal pathogens were reported and 14% grew no organism. Optimal imaging modality for diagnosis or follow-up was unclear. Median antimicrobial therapy duration was 7.2 weeks, with no definitive evidence for optimal regimens. Twenty-one percent had surgery with widely variable timing, indication, or procedure. One-year disease-specific mortality was 2%; treatment failure and relapse rates were 22% and 7%, respectively.
Conclusion: There is a lack of robust, high-quality data to support best practice for diagnosis and management for this neglected condition. A minimum set of reporting requirements is proposed for future studies. A consensus case definition is urgently needed to facilitate high-quality research.
Tabashiri A, Allahverdi Nazhand H, Fathy M, Mortazavi S, Javandoust Gharehbagh F, Haghighi-Morad M BMC Infect Dis. 2025; 25(1):277.
PMID: 40000962 PMC: 11863464. DOI: 10.1186/s12879-025-10637-8.
AlSharhan S, Alwazzeh M, ALRammah M, ALMarzouq W, AlGhuneem A, Alshrefy A Infez Med. 2024; 32(3):340-351.
PMID: 39282550 PMC: 11392546. DOI: 10.53854/liim-3203-8.
Vosbeek E, Straatman L, Braat A, de Keizer B, Thomeer H, Smit A Otol Neurotol Open. 2024; 3(4):e042.
PMID: 38516544 PMC: 10950167. DOI: 10.1097/ONO.0000000000000042.
Epidemiology and risk factors for extension of necrotizing otitis externa.
Krawiec E, Brenet E, Truong F, NGuyen Y, Papthanassiou D, Labrousse M Eur Arch Otorhinolaryngol. 2024; 281(5):2383-2394.
PMID: 38499694 DOI: 10.1007/s00405-024-08549-5.
Pugliese G, Maccari A, Felisati E, Felisati G, Giudici L, Rapolla C Clin Case Rep. 2023; 11(9):e7933.
PMID: 37736475 PMC: 10509342. DOI: 10.1002/ccr3.7933.